148 related articles for article (PubMed ID: 31649850)
1. Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.
Chen L; Chen L; Qin Z; Lei J; Ye S; Zeng K; Wang H; Ying M; Gao J; Zeng S; Yu L
Acta Pharm Sin B; 2019 Sep; 9(5):1008-1020. PubMed ID: 31649850
[TBL] [Abstract][Full Text] [Related]
2. Regulation of
Zhu Q; Yu L; Qin Z; Chen L; Hu H; Zheng X; Zeng S
Epigenetics; 2019 Aug; 14(8):791-803. PubMed ID: 31088315
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
Liu Y; Zheng X; Yu Q; Wang H; Tan F; Zhu Q; Yuan L; Jiang H; Yu L; Zeng S
Sci Transl Med; 2016 Jul; 8(348):348ra97. PubMed ID: 27440728
[TBL] [Abstract][Full Text] [Related]
4. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Chen L; Wang Z; Xu Q; Liu Y; Chen L; Guo S; Wang H; Zeng K; Liu J; Zeng S; Yu L
Theranostics; 2020; 10(8):3562-3578. PubMed ID: 32206108
[No Abstract] [Full Text] [Related]
5. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
7. miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.
Jin L; Li Y; Zhang Z; He T; Hu J; Liu J; Chen M; Gui Y; Yang S; Mao X; Chen Y; Lai Y
Oncol Lett; 2017 Nov; 14(5):5624-5630. PubMed ID: 29113192
[TBL] [Abstract][Full Text] [Related]
8. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation is induced in renal cell carcinoma through miR-92a-3p upregulation by targeting FBXW7.
Zeng R; Huang J; Sun Y; Luo J
Oncol Lett; 2020 Apr; 19(4):3258-3268. PubMed ID: 32256821
[TBL] [Abstract][Full Text] [Related]
10. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
Liu F; Chen N; Xiao R; Wang W; Pan Z
Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
[TBL] [Abstract][Full Text] [Related]
11. MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma.
Ke X; Zeng X; Wei X; Shen Y; Gan J; Tang H; Hu Z
Am J Transl Res; 2017; 9(12):5332-5346. PubMed ID: 29312487
[TBL] [Abstract][Full Text] [Related]
12. PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway.
Hou P; Li H; Yong H; Chen F; Chu S; Zheng J; Bai J
Angiogenesis; 2019 Nov; 22(4):507-519. PubMed ID: 31254127
[TBL] [Abstract][Full Text] [Related]
13. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
14. miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5.
Zhang X; Wang C; Li H; Niu X; Liu X; Pei D; Guo X; Xu X; Li Y
Oncotarget; 2017 Sep; 8(38):64106-64113. PubMed ID: 28969055
[TBL] [Abstract][Full Text] [Related]
15. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
16. DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.
Chen C; Xue S; Zhang J; Chen W; Gong D; Zheng J; Ma J; Xue W; Chen Y; Zhai W; Zheng J
Int J Cancer; 2017 Nov; 141(9):1867-1878. PubMed ID: 28657135
[TBL] [Abstract][Full Text] [Related]
17. Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.
Gaudelot K; Gibier JB; Pottier N; Hémon B; Van Seuningen I; Glowacki F; Leroy X; Cauffiez C; Gnemmi V; Aubert S; Perrais M
Tumour Biol; 2017 Jul; 39(7):1010428317707372. PubMed ID: 28714373
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-338-3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma.
Tong Z; Meng X; Wang J; Wang L
Exp Ther Med; 2017 Nov; 14(5):5200-5206. PubMed ID: 29201237
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1.
Li S; Yang J; Wang J; Gao W; Ding Y; Ding Y; Jia Z
Cell Biosci; 2018; 8():9. PubMed ID: 29445446
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
